186 related articles for article (PubMed ID: 28927718)
1. Metabolic profiling of the effects of ginsenoside Re in an Alzheimer's disease mouse model.
Li J; Liu Y; Li W; Wang Z; Guo P; Li L; Li N
Behav Brain Res; 2018 Jan; 337():160-172. PubMed ID: 28927718
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study.
Li N; Zhou L; Li W; Liu Y; Wang J; He P
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():54-61. PubMed ID: 25660715
[TBL] [Abstract][Full Text] [Related]
3. A UHPLC-TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model.
Gong Y; Liu Y; Zhou L; Di X; Li W; Li Q; Bi K
J Pharm Biomed Anal; 2015 Nov; 115():174-82. PubMed ID: 26210744
[TBL] [Abstract][Full Text] [Related]
4. Effects of breviscapine on amyloid beta 1-42 induced Alzheimer's disease mice: A HPLC-QTOF-MS based plasma metabonomics study.
Xia H; Wu L; Chu M; Feng H; Lu C; Wang Q; He M; Ge X
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1057():92-100. PubMed ID: 28511119
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
6. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
[TBL] [Abstract][Full Text] [Related]
7. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
8. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease.
Li N; Liu Y; Li W; Zhou L; Li Q; Wang X; He P
J Ginseng Res; 2016 Jan; 40(1):9-17. PubMed ID: 26843817
[TBL] [Abstract][Full Text] [Related]
9. A metabolomic study based on accurate mass and isotopic fine structures by dual mode combined-FT-ICR-MS to explore the effects of Rhodiola crenulata extract on Alzheimer disease in rats.
Zhang X; Jiang X; Wang X; Zhao Y; Jia L; Chen F; Yin R; Han F
J Pharm Biomed Anal; 2019 Mar; 166():347-356. PubMed ID: 30690248
[TBL] [Abstract][Full Text] [Related]
10. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
[TBL] [Abstract][Full Text] [Related]
11. Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β
Liang S; Wang Z; Yuan J; Zhang J; Dai X; Qin F; Zhang J; Sun Y
Molecules; 2019 Jul; 24(14):. PubMed ID: 31315255
[TBL] [Abstract][Full Text] [Related]
12. Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.
Pinz MP; Dos Reis AS; Vogt AG; Krüger R; Alves D; Jesse CR; Roman SS; Soares MP; Wilhelm EA; Luchese C
Biomed Pharmacother; 2018 Sep; 105():1006-1014. PubMed ID: 30021335
[TBL] [Abstract][Full Text] [Related]
13. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic signatures in peripheral blood associated with Alzheimer's disease amyloid-β-induced neuroinflammation.
Kim E; Jung YS; Kim H; Kim JS; Park M; Jeong J; Lee SK; Yoon HG; Hwang GS; Namkoong K
J Alzheimers Dis; 2014; 42(2):421-33. PubMed ID: 24898638
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
16. Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an A
Yi M; Zhang C; Zhang Z; Yi P; Xu P; Huang J; Peng W
Oxid Med Cell Longev; 2020; 2020():5243453. PubMed ID: 32655770
[TBL] [Abstract][Full Text] [Related]
17. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
Liu Y; Li N; Zhou L; Li Q; Li W
Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
[TBL] [Abstract][Full Text] [Related]
19. Ginsenosides attenuate d-galactose- and AlCl
Zhang Y; Pi Z; Song F; Liu Z
J Ethnopharmacol; 2016 Dec; 194():188-195. PubMed ID: 27612432
[TBL] [Abstract][Full Text] [Related]
20. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
